Status:
UNKNOWN
Pulmonary Function Assessment and Evaluation Using Self-administrable and Portable Electrical Impedance Tomography
Lead Sponsor:
Queen Mary Hospital, Hong Kong
Conditions:
Lung Diseases
Eligibility:
All Genders
18-75 years
Brief Summary
Spirometry is the most commonly used modality for measuring lung function. However, spirometry is a coordination-dependent test and may lead to erroneous results if subjects are unable to fully comply...
Eligibility Criteria
Inclusion
- Pulmonary disease subjects Patients of age 18 to 75 suspected or diagnosed with pulmonary diseases scheduled to undergo standard pulmonary function test will be recruited. These patients will undergo an interview (with a structured questionnaire), Pulmonary Functional Test (PFT) and EIT examination.
- Healthy control subjects Healthy adults of age 18 to 75 who do not have any known pulmonary diseases will be examined. These healthy individuals will undergo spirometry and EIT examination, as well as an interview with a structured questionnaire to ensure they do not have any clinical features or symptoms.
Exclusion
- Subjects with implanted electronic devices, in case EIT might interfere with the devices
- Subjects with spinal diseases
- Subjects with unstable cardiac or respiratory conditions
- Pregnant women
- Patients who are unable to perform spirometry
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT05346081
Start Date
May 1 2023
End Date
June 30 2025
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong